Physiologically Based Biopharmaceutics Modelling—Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report.
Saved in:
| Title: | Physiologically Based Biopharmaceutics Modelling—Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report. |
|---|---|
| Authors: | McAllister, Mark1 (AUTHOR), Mistry, Nena2 (AUTHOR), Pepin, Xavier3 (AUTHOR), Cole, Susan4 (AUTHOR), Tannergren, Christer5 (AUTHOR), Stamatopoulos, Konstantinos2,6 (AUTHOR), Engman, Helena5,7 (AUTHOR), Moir, Andrea6,8 (AUTHOR), Litou, Chara7,9 (AUTHOR), Gavins, Francesca4,10 (AUTHOR), Arora, Sumit8,11 (AUTHOR), Malamatari, Maria4,12 (AUTHOR), Guimarães, Mariana9,13 (AUTHOR), Ravi, Aishwarya10,14 (AUTHOR), Fotaki, Nikoletta1,11 (AUTHOR), Dodd, Laurence2,9 (AUTHOR), Holte, Øyvind3,12 (AUTHOR), Butler, James2,4 (AUTHOR), Dickinson, Paul A.5,13 (AUTHOR), Popkin, Matt6,14 (AUTHOR) |
| Source: | Pharmaceutics. May2026, Vol. 18 Issue 5, p566. 36p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19994923 |
|---|---|
| DOI: | 10.3390/pharmaceutics18050566 |
